Diabetes-Metabolism Research and Reviews
Impact Factor Trend (2020–2026)
Clarivate IF trend for Diabetes-Metabolism Research and Reviews
SCImago Journal Rank citation prestige weighting
146 papers with at least that number of citations each
Aims & Scope
Diabetes/Metabolism Research and Reviews is an indispensable resource for clinicians and researchers working in the fields of diabetes, endocrinology, metabolism and obesity. Our reviews section provides the latest updates on clinical and basic scientific advances in key areas of diabetes, obesity and metabolism, important historical overviews, discussion of controversial issues and opinions from prominent researchers and clinicians. Original articles describing clinical studies, translational and basic research related to diabetes, obesity, metabolism, or closely related metabolic disorders are welcome, as are articles concerned with treatment and management issues related to patient care.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
ENDOCRINOLOGY & METABOLISM
ENDOCRINOLOGY & METABOLISM
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisDiabetes-Metabolism Research and Reviews (acronym: dmrr, abbr: DIABETES-METAB RES, ISSN: 1520-7552) is a peer-reviewed international scholarly journal in the field of Medicine, published by John Wiley and Sons Ltd in United States since 1999. The periodical holds a Journal Impact Factor (JIF) of 8.30, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.030 (Q1), an H-index of 146.
The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 67 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,744 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics